William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Towerview LLC Has $500,000 Position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Towerview LLC Has $500,000 Stock Position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They currently have a $4.00 price objective on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 148.45% from the company’s previous close. […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its price objective boosted by LADENBURG THALM/SH SH from $10.00 to $12.00 in a report issued on Monday, FlyOnTheWall reports. CRVS has been the topic of a number of other reports. StockNews.com began coverage on shares of Corvus Pharmaceuticals in a report on Thursday, May 18th. They set […]